<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="68894">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02008240</url>
  </required_header>
  <id_info>
    <org_study_id>Hydrosalpinx2</org_study_id>
    <nct_id>NCT02008240</nct_id>
  </id_info>
  <brief_title>Salpingectomy Versus Aspiration of Hydrosalpingeal Fluid Prior to IVF-ET</brief_title>
  <official_title>Salpingectomy Versus Aspiration of Hydrosalpingeal Fluid Prior to IVF-ET.A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aljazeera Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aljazeera Hospital</source>
  <oversight_info>
    <authority>Egypt: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this randomized controlled trial is to compare the efficacy of ultrasound guided
      aspiration of hydrosalpingeal fluid with salpingectomy in the management patients with
      ultrasound visible hydrosalpinges undergoing IVF-ET.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The adverse impact of hydrosalpinx on in vitro fertilisation embryo transfer (IVF-ET)
      outcomes has been confirmed by several retrospective and prospective studies .

      Cochrane review of prospective randomised trials of laparoscopic salpingectomy confirmed the
      beneficial effect of laparoscopic salpingectomy on IVF-ET outcomes in patients with
      hydrosalpinges.

      Surgery is not usually safe especially in patients with extensive adhesions, morbid obesity
      or previous multiple laparotomies. Furthermore, many infertile couples refuse to undergo
      bilateral salpingectomy or proximal tubal occlusion because these procedures remove any hope
      of spontaneous pregnancy. Other less invasive options for patients with hydrosalpinges as
      ultrasound-guided aspiration of hydrosalpingeal fluid, antibiotics (alone or combined with
      aspiration) and hysteroscopic occlusion of fallopian tube were studied in order to find an
      alternative to salpingectomy . Although these methods are simple and getting popular,
      current data are inadequate to recommend these treatment options instead of salpingectomy
      because most of the supporting evidences for these methods come from small retrospective
      studies.

      A recent randomized controlled trial revealed that the aspiration of hydrosalpingeal fluid
      at the time of oocyte retrieval was associated with improved implantation rate and pregnancy
      rates.

      The aim of this randomized controlled trial is to compare the efficacy of ultrasound guided
      aspiration of hydrosalpingeal fluid with salpingectomy in the management patients with
      ultrasound visible hydrosalpinges undergoing IVF-ET
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2011</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Anticipated">February 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>The Number of Participants Who Achieved Clinical Pregnancy in a Transfer Cycle</measure>
    <time_frame>5 weeks after embryo transfer</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Number of Participants Who Achieved Ongoing Pregnancy in a Transfer Cycle .</measure>
    <time_frame>18 weeks after embryo transfer</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Needle aspiration of hydrosalpinx</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Aspiration of hydrosalpingeal fluid under ultrasound guidance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>salpingectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Surgical removal of hydrosalpinx</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Needle aspiration of hydrosalpinx</intervention_name>
    <description>Under deep sedation, the retrieval of oocytes is done and then an aspiration needle is inserted into the hydrosalpinx under ultrasonographic guidance and suction is applied to aspirate the hydrosalpingeal fluid completely . If there are bilateral hydrosalpinges, the process is repeated on the opposite side.</description>
    <arm_group_label>Needle aspiration of hydrosalpinx</arm_group_label>
    <other_name>ultrasound guidance aspiration of hydrosalpingeal fluid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Salpingectomy</intervention_name>
    <description>laparoscopic surgical removal of affected tube is done with bipolar electrocoagulation for hemostasis. The mesosalpinx is coagulated as close a possible to the fallopian tube to avoid any compromise in the ovarian blood supply . In cases with marked adhesion, proximal ligation and a distal fenestration is done .</description>
    <arm_group_label>salpingectomy</arm_group_label>
    <other_name>surgical removal of hydrosalpinx</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with unilateral or bilateral hydrosalpinges visible by ultrasound

          -  Age between 18 - 37 years

          -  Period of infertility &gt; 1 year

          -  Body mass index between 19-29

          -  Normal basal luteinizing hormone (LH), follicle stimulating hormone (FSH) and
             prolactin concentrations.

          -  Normal recent semen analysis (according to World Health Organization criteria).

        Exclusion Criteria:

          -  Uterine fibroid requiring surgical removal.

          -  Endometriosis.

          -  Male factor of infertility requiring ICSI, Previous IVF cycles.

          -  History of recurrent miscarriage.

          -  Endocrinologic disorders.

          -  Presence of systemic disease contraindicating pregnancy.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>37 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Usama M. Fouda, M.D , PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Assistant professor of Obstetrics and Gynecology , Faculty of medicine ,Cairo university</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ahmed M. Sayed, M.D , PhD</last_name>
    <role>Study Director</role>
    <affiliation>Assistant professor of Obstetrics and Gynecology , Faculty of medicine ,Cairo university</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Usama M. Fouda, M.D, PhD</last_name>
    <phone>+201099930213</phone>
    <email>umfrfouda@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Aljazeera hospital</name>
      <address>
        <city>Giza</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Usama M. Fouda, M.D , PhD</last_name>
      <phone>+0201099930213</phone>
      <email>umfrfouda@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Usama M. Fouda, M.D , PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ahmed M. Sayed, M.D , PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Fouda UM, Sayed AM. Effect of ultrasound-guided aspiration of hydrosalpingeal fluid during oocyte retrieval on the outcomes of in vitro fertilisation-embryo transfer: a randomised controlled trial (NCT01040351). Gynecol Endocrinol. 2011 Aug;27(8):562-7. Epub 2010 Jul 30.</citation>
    <PMID>20672903</PMID>
  </reference>
  <reference>
    <citation>Strandell A, Lindhard A, Waldenstr√∂m U, Thorburn J, Janson PO, Hamberger L. Hydrosalpinx and IVF outcome: a prospective, randomized multicentre trial in Scandinavia on salpingectomy prior to IVF. Hum Reprod. 1999 Nov;14(11):2762-9.</citation>
    <PMID>10548619</PMID>
  </reference>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 8, 2013</lastchanged_date>
  <firstreceived_date>December 8, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aljazeera Hospital</investigator_affiliation>
    <investigator_full_name>Prof .Usama M.Fouda</investigator_full_name>
    <investigator_title>M.D , PhD</investigator_title>
  </responsible_party>
  <keyword>Infertility</keyword>
  <keyword>Hydrosalpinx</keyword>
  <keyword>IVF-ET</keyword>
  <keyword>Salpingectomy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
